China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.23

(0.0%)

Long Term Debt Summary of China Pioneer Pharma Holdings Limited

  • China Pioneer Pharma Holdings Limited's latest annual long term debt in 2023 was 12.74 Million CNY , up 59.21% from previous year.
  • China Pioneer Pharma Holdings Limited's latest quarterly long term debt in 2023 FY was 12.74 Million CNY , up 59.21% from previous quarter.
  • China Pioneer Pharma Holdings Limited reported annual long term debt of 8 Million CNY in 2022, up 11177.46% from previous year.
  • China Pioneer Pharma Holdings Limited reported annual long term debt of 71 Thousand CNY in 2021, down 0.0% from previous year.
  • China Pioneer Pharma Holdings Limited reported quarterly long term debt of 12.74 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • China Pioneer Pharma Holdings Limited reported quarterly long term debt of 12.74 Million CNY for 2023 FY, up 59.21% from previous quarter.

Annual Long Term Debt Chart of China Pioneer Pharma Holdings Limited (2023 - 2012)

Historical Annual Long Term Debt of China Pioneer Pharma Holdings Limited (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 12.74 Million CNY 59.21%
2022 8 Million CNY 11177.46%
2021 71 Thousand CNY 0.0%
2020 - CNY -100.0%
2019 69 Thousand CNY 0.0%
2018 - CNY -100.0%
2017 4.79 Million CNY -57.32%
2016 11.23 Million CNY -26.73%
2015 15.33 Million CNY 77.57%
2014 8.63 Million CNY 1776.74%
2013 460 Thousand CNY 0.0%
2012 - CNY 0.0%

Peer Long Term Debt Comparison of China Pioneer Pharma Holdings Limited

Name Long Term Debt Long Term Debt Difference
China Healthwise Holdings Limited 2.14 Million HKD -493.206%
Tycoon Group Holdings Limited 8.89 Million HKD -43.333%
Beijing Tong Ren Tang Chinese Medicine Company Limited 166 Thousand HKD -7579.518%